NCT07533942 2026-04-16A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 MeningiomaJazz PharmaceuticalsPhase 2 Not yet recruiting30 enrolled
NCT04541082 2025-12-18Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System NeoplasmsJazz PharmaceuticalsPhase 1 Recruiting102 enrolled